CAPTRUST Financial Advisors
OPRX icon

CAPTRUST Financial Advisors’s OptimizeRx OPRX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,723
Closed -$325K – 2498
2023
Q4 		$325K Sell
22,723
-145
-0.6% -$1.39K ﹤0.01% 2058
2023
Q3 		$178K Buy
+22,868
New +$249K ﹤0.01% 2321
2022
Q3 		– Sell
-1,287
Closed -$35K – 3401
2022
Q2 		$35K Buy
1,287
+918
+249% +$27.2K ﹤0.01% 3015
2022
Q1 		$14K Buy
369
+31
+9% +$1.37K ﹤0.01% 3613
2021
Q4 		$21K Buy
338
+19
+6% +$1.44K ﹤0.01% 3255
2021
Q3 		$27K Hold
319
– – ﹤0.01% 2962
2021
Q2 		$20K Buy
319
+19
+6% +$967 ﹤0.01% 3113
2021
Q1 		$15K Hold
300
– – ﹤0.01% 3199
2020
Q4 		$9K Buy
+300
New +$7.35K ﹤0.01% 2626

Other funds holding OPRX

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

CAPTRUST Financial Advisors's OPRX Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of OptimizeRx (OPRX) in Q1 2024, closing a stake of 22,723 shares — an estimated $325K sold.

CAPTRUST Financial Advisors first reported a position in OPRX in Q4 2020 and held it in 9 quarters. The position peaked at $325K in Q4 2023. 97 funds tracked by Wall St. Rank hold OPRX as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining OptimizeRx position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 22,723 OptimizeRx shares in Q1 2024, an estimated $325K.
  • CAPTRUST Financial Advisors first reported a position in OptimizeRx in Q4 2020 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's OptimizeRx position peaked at $325K in Q4 2023.
  • 97 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.